| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.07B | +13.7% |
| Cost of Revenue | $2.59B | +18.7% |
| Gross Profit | $2.48B | +8.8% |
| R&D Expense | $1.02B | +1.1% |
| SG&A Expense | $410.7M | -8.6% |
| Operating Income | $157.8M | +393.8% |
| Pre-tax Income | $55.1M | +162.2% |
| Income Tax | $21.3M | +2.3% |
| Net Income | $33.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $682.3M | +62.0% |
| Accounts Receivable | $636.7M | +8.2% |
| Current Assets | $3.58B | +3.8% |
| Total Assets | $9.77B | -1.0% |
| Current Liabilities | $887.0M | +8.1% |
| Long-term Debt | $992.3M | +0.2% |
| Total Liabilities | $1.95B | +1.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.00B | +40.1% |
| Investing Cash Flow | $80.9M | -94.1% |
| Financing Cash Flow | -$833.1M | +64.0% |
| +130.9% |
| EPS (Basic) | $0.22 | +133.3% |
| EPS (Diluted) | $0.21 | +131.8% |
| Stockholders' Equity |
| $7.82B |
| -1.7% |